JERSEY CITY, N.J. , June 21, 2024 /PRNewswire/ -- InsightAce Analytic Pvt.
Ltd. announces the release of a market assessment report on the " Targeted Protein Degradation Market "- Distribution by Type of Degrader (SERD, PROTAC and Molecular Glue), Target Indication (Breast Cancer and Multiple Myeloma), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031." The Targeted Protein Degradation Market is estimated to reach over USD 2.
65 Bn by 2031, exhibiting a CAGR of 26.3% during the forecast period. Targeted protein degradation (TPD) seeks to completely remove specific proteins from the cell, rather than merely inhibiting their activity.
This approach can potentially provide more effective and sustained treatment outcomes for various diseases by thoroughly eliminating disease-causing proteins. By leveraging the cell's natural degradation pathways, TPD can address issues that traditional therapies cannot, such as drug resistance and incomplete inhibition. Consequently, this innovative strategy holds significant promise for advancing the treatment of conditions like cancer, neurodegenerative diseases, and infectious diseases, offering new hope for patients with previously intractable conditions.
Targeted protein degradation (TPD) seeks to completely remove specific proteins from the cell, rather than merely inhibiting their activity. This approach can potentially provide more effective and sustained treatment outcomes for various diseases by th.
